Research Summary

Dr. Anya Levinson is a pediatric hematologist-oncologist who specializes in treating blood cancers, such as leukemia and lymphoma. In her research, Dr. Levinson studies ways to improve survival and decrease the toxic effects of treatment for children with leukemia. She focuses on steroid resistance in T-cell acute lymphoblastic leukemia and on targeted therapies for acute myeloid leukemia. She is an associate program director for the pediatric hematology/oncology fellowship at UCSF.


  • Princeton University, BA, 2009, Ecology and Evolutionary Biology
  • Columbia University College of Physicians & Surgeons, MD, 2014, Medicine
  • Morgan Stanley Children's Hospital of NYP, Residency, 2017, Pediatrics
  • University of California San Francisco, Fellowship, 2020, Pediatric Hematology/Oncology

Honors & Awards

  • 2023-2025
    Hyundai Hope on Wheels Young Investigator Grant
  • 2022-2025
    Department of Defense, Peer Reviewed Cancer Research Program Career Development Award
  • 2021-2022
    NCI Developmental and Hyperactive Ras Tumor SPORE Career Enhancement Program
  • 2020-2022
    St. Baldrick’s Foundation / Ty Louis Campbell Foundation Fellow
  • 2020-2022/2023
    Chan Zuckerberg Institute Biohub Physician-Scientist Fellow
  • 2018-2020
    NIH T32 Research Grant (5T32CA128583)
  • 2018
    AACR Molecular Biology in Clinical Oncology Workshop
  • 2014
    Miriam Berkman Spotnitz Award
  • 2014
    P&S Sara and Arnold P. Friedman Award
  • 2014
    Columbia P&S Student Research Day Award  

Selected Publications

  1. Levinson A, Lee AG, Martell HJ, Breese MR, Zaloudek C, Van Ziffle J, Laguna B, Leung SG, Chen MD, Chen LM, Pfeil J, Ladwig NR, Shah AT, Behroozfard I, Rao AA, Salama SR, Sweet-Cordero EA, Stieglitz E. Complete Response to PD-1 Inhibition in an Adolescent With Relapsed Clear Cell Adenocarcinoma of the Cervix Predicted by Neoepitope Burden and APOBEC Signature. JCO Precis Oncol. 2020 Nov 2;4:PO.20.00132.
    View on PubMed
  2. Smith GA, Levinson AL, Galvin RT, Lalor LE, McCalmont T, Wang L, Geis MC, Odegaard K, Hupp M, Maguiness S, Turcotte LM, Cordoro KM, Hermiston ML. Concurrent Subcutaneous Panniculitis-like T-Cell Lymphoma and B-Cell Acute Lymphoblastic Leukemia in 2 Pediatric Patients. J Pediatr Hematol Oncol. 2020 Aug 26.
    View on PubMed
  3. Levinson A, Arnold S, Jin Z, Bhatia M, George D, Garvin JH, Satwani P. Timing and Utility of Relapse Surveillance after Allogeneic Hematopoietic Cell Transplantation in Children with Leukemia. Biol Blood Marrow Transplant. 2017 Apr;23(4):696-700.
    View on PubMed
  4. Satwani P, Freedman JL, Chaudhury S, Jin Z, Levinson A, Foca MD, Krajewski J, Sahdev I, Talekar MK, Gardenswartz A, Silverman J, Hayes M, Dvorak CC. A Multicenter Study of Bacterial Blood Stream Infections in Pediatric Allogeneic Hematopoietic Cell Transplantation Recipients: The Role of Acute Gastrointestinal Graft-versus-Host Disease. Biol Blood Marrow Transplant. 2017 Apr;23(4):642-647.
    View on PubMed
  5. Chang AK, Foca MD, Jin Z, Vasudev R, Laird M, Schwartz S, Qureshi M, Kolb M, Levinson A, Bhatia M, Kung A, Garvin J, George D, Della-Latta P, Whittier S, Saiman L, Satwani P. Bacterial bloodstream infections in pediatric allogeneic hematopoietic stem cell recipients before and after implementation of a central line-associated bloodstream infection protocol: A single-center experience. Am J Infect Control. 2016 Dec 1;44(12):1650-1655.
    View on PubMed
  6. Al Mulla N, Kahn JM, Jin Z, Qureshi M, Karamehmet E, Yoon-Jeong Kim G, Levinson AL, Bhatia M, Garvin JH, George D, Kung AL, Satwani P. Survival Impact of Early Post-Transplant Toxicities in Pediatric and Adolescent Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Malignant and Nonmalignant Diseases: Recognizing Risks and Optimizing Outcomes. Biol Blood Marrow Transplant. 2016 Aug;22(8):1525-1530.
    View on PubMed
  7. Levinson A, Pinkney K, Jin Z, Bhatia M, Kung AL, Foca MD, George D, Garvin JH, Sosna J, Karamehmet E, Robinson C, Satwani P. Acute gastrointestinal graft-vs-host disease is associated with increased enteric bacterial bloodstream infection density in pediatric allogeneic hematopoietic cell transplant recipients. Clin Infect Dis. 2015 Aug 1;61(3):350-7.
    View on PubMed

Go to UCSF Profiles, powered by CTSI